Loading...

Stock Performance

Data Provided by Refinitiv. Minimum 15 minutes delayed.


众太坊最新利- 爬墙专用加速器

July 31, 2024 - Apellis Pharmaceuticals Reports Second Quarter 2024 Financial Results July 7, 2024 - Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA) July 2, 2024 - Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

众太坊最新利- 爬墙专用加速器

众太坊最新利- 爬墙专用加速器

Investor Relations:
Argot Partners
Sam Martin / Maghan Meyers
(212) 600-1902
Email: sam@argotpartners.com / maghan@argotpartners.com

Media Relations:
Tracy Vineis
(617) 420-4839
Email: media@apellis.com

众太坊最新利- 爬墙专用加速器

Sign up to receive email alerts whenever Apellis Pharmaceuticals, Inc. posts new information to the site. Just enter your email address and click Submit.

Sign Up
加速网络连接 Email Alerts RSS Feeds Contact IR
国内vp加速器免费  快连加速器pc端  极光v  回锅肉加速器官网v  快连加速器官网下载安卓  免费vqn加速,免费vqn加速外网-,苹果加速免费永久ios,爬墙专用加速器  坚果加速器破解版,坚果加速器免费试用,坚果加速器不能用了,坚果加速器打不开了